A GSK-3-mediated transcriptional network maintains repression of immediate early genes in quiescent cells

References

• Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 2003; 116:1175 - 1186; PMID: 12615961; http://dx.doi.org/10.1242/jcs.00384
   PubMed Web of Science ®Google Scholar
• Frame S, Cohen P. GSK3 takes centre stage more than 20 years after its discovery. Biochem J 2001; 359:1 - 16; PMID: 11563964; http://dx.doi.org/10.1042/0264-6021:3590001
   PubMed Web of Science ®Google Scholar
• Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci 2004; 29:95 - 102; PMID: 15102436; http://dx.doi.org/10.1016/j.tibs.2003.12.004
   PubMed Web of Science ®Google Scholar
• Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20:781 - 810; PMID: 15473860; http://dx.doi.org/10.1146/annurev.cellbio.20.010403.113126
   PubMed Web of Science ®Google Scholar
• Hardt SE, Tomita H, Katus HA, Sadoshima J. Phosphorylation of eukaryotic translation initiation factor 2B-ε by glycogen synthase kinase-3β regulates β-adrenergic cardiac myocyte hypertrophy. Circ Res 2004; 94:926 - 935; PMID: 15001529; http://dx.doi.org/10.1161/01.RES.0000124977.59827.80
   PubMed Web of Science ®Google Scholar
• Pap M, Cooper GM. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase3β signaling pathway. Mol Cell Biol 2002; 22:578 - 586; PMID: 11756553; http://dx.doi.org/10.1128/MCB.22.2.578-86.2002
   PubMed Web of Science ®Google Scholar
• Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499 - 3511; PMID: 9832503; http://dx.doi.org/10.1101/gad.12.22.3499
   PubMed Web of Science ®Google Scholar
• Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006; 21:749 - 760; PMID: 16543145; http://dx.doi.org/10.1016/j.molcel.2006.02.009
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Zubova SG, Bukreeva EI, Pospelov VA, Pospelova TV, Blagosklonny MV. Rapamycin decelerates cellular senescence. Cell Cycle 2009; 8:1888 - 1895; PMID: 19471117; http://dx.doi.org/10.4161/cc.8.12.8606
   PubMed Web of Science ®Google Scholar
• Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010; 2:344 - 352; PMID: 20606252
   PubMedGoogle Scholar
• Stein GH. T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. J Cell Physiol 1979; 99:43 - 54; PMID: 222778; http://dx.doi.org/10.1002/jcp.1040990107
   PubMed Web of Science ®Google Scholar
• Tullai JW, Schaffer ME, Mullenbrock S, Kasif S, Cooper GM. Identification of transcription factor binding sites upstream of human genes regulated by the phosphatidylinositol-3-kinase and MEK/ERK signaling pathways. J Biol Chem 2004; 279:20167 - 20177; PMID: 14769801; http://dx.doi.org/10.1074/jbc.M309260200
   PubMed Web of Science ®Google Scholar
• Bromann PA, Korkaya H, Webb CP, Miller J, Calvin TL, Courtneidge SA. Platelet-derived growth factor stimulates Src-dependent mRNA stabilization of specific early genes in fibroblasts. J Biol Chem 2005; 280:10253 - 10263; PMID: 15637050; http://dx.doi.org/10.1074/jbc.M413806200
   PubMed Web of Science ®Google Scholar
• Gu J, Iyer VR. PI3K signaling and miRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli. Genome Biol 2006; 7:42; PMID: 16737555; http://dx.doi.org/10.1186/gb-2006-7-5-r42
   PubMed Web of Science ®Google Scholar
• Hjortsberg L, Lindvall C, Corcoran M, Arulampalam V, Chan D, Thyrell L, et al. Phosphoinositide-3-kinase regulates a subset of interferon-α-stimulated genes. Exp Cell Res 2007; 313:404 - 414; PMID: 17141757; http://dx.doi.org/10.1016/j.yexcr.2006.10.022
   PubMed Web of Science ®Google Scholar
• Jürchott K, Kuban RJ, Krech T, Bluthgen N, Stein U, Walther W, et al. Identification of Y-box binding protein 1 as a core regulator of MEK/ERK pathway-dependent gene signatures in colorectal cancer cells. PLoS Genet 2010; 6:1001231; PMID: 21170361; http://dx.doi.org/10.1371/journal.pgen.1001231
   PubMed Web of Science ®Google Scholar
• Ulici V, James CG, Hoenselaar KD, Beier F. Regulation of gene expression by PI3K in mouse growth plate chondrocytes. PLoS ONE 2010; 5:8866; PMID: 20111593; http://dx.doi.org/10.1371/journal.pone.0008866
   PubMed Web of Science ®Google Scholar
• Tullai JW, Chen J, Schaffer ME, Kamenetsky E, Kasif S, Cooper GM. Glycogen synthase kinase-3 represses cyclic AMP response element-binding protein (CREB)-targeted immediate early genes in quiescent cells. J Biol Chem 2007; 282:9482 - 9491; PMID: 17277356; http://dx.doi.org/10.1074/jbc.M700067200
   PubMed Web of Science ®Google Scholar
• Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004; 5:276 - 287; PMID: 15131651; http://dx.doi.org/10.1038/nrg1315
   PubMed Web of Science ®Google Scholar
• Sauer T, Shelest E, Wingender E. Evaluating phylogenetic footprinting for human-rodent comparisons. Bioinformatics 2006; 22:430 - 437; PMID: 16332706; http://dx.doi.org/10.1093/bioinformatics/bti819
   PubMed Web of Science ®Google Scholar
• Graham JR, Tullai JW, Cooper GM. GSK-3 represses growth factor-inducible genes by inhibiting NFκB in quiescent cells. J Biol Chem 2010; 285:4472 - 4480; PMID: 20018891; http://dx.doi.org/10.1074/jbc.M109.053785
   PubMed Web of Science ®Google Scholar
• Conkright MD, Guzman E, Flechner L, Su AI, Hogenesch JB, Montminy M. Genome-wide analysis of CREB target genes reveals A core promoter requirement for cAMP responsiveness. Mol Cell 2003; 11:1101 - 1108; PMID: 12718894; http://dx.doi.org/10.1016/S1097-2765(03)00134-5
   PubMed Web of Science ®Google Scholar
• Bullock BP, Habener JF. Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation and increases net charge. Biochemistry 1998; 37:3795 - 3809; PMID: 9521699; http://dx.doi.org/10.1021/bi970982t
   PubMed Web of Science ®Google Scholar
• Grimes CA, Jope RS. CREB DNA binding activity is inhibited by glycogen synthase kinase-3β and facilitated by lithium. J Neurochem 2001; 78:1219 - 1232; PMID: 11579131; http://dx.doi.org/10.1046/j.14714159.2001.00495.x
   PubMed Web of Science ®Google Scholar
• Liang MH, Chuang DM. Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation. J Biol Chem 2006; 281:30479 - 30484; PMID: 16912034; http://dx.doi.org/10.1074/jbc.M607468200
   PubMed Web of Science ®Google Scholar
• Martin M, Rehani K, Jope RS, Michalek SM. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol 2005; 6:777 - 784; PMID: 16007092; http://dx.doi.org/10.1038/ni1221
   PubMed Web of Science ®Google Scholar
• Schreiber J, Jenner RG, Murray HL, Gerber GK, Gifford DK, Young RA. Coordinated binding of NFκB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 2006; 103:5899 - 5904; PMID: 16595631; http://dx.doi.org/10.1073/pnas.0510996103
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Shared principles in NFκB signaling. Cell 2008; 132:344 - 362; PMID: 18267068; http://dx.doi.org/10.1016/j.cell.2008.01.020
   PubMed Web of Science ®Google Scholar
• Gong R, Rifai A, Ge Y, Chen S, Dworkin LD. Hepatocyte growth factor suppresses proinflammatory NFκB activation through GSK3β inactivation in renal tubular epithelial cells. J Biol Chem 2008; 283:7401 - 7410; PMID: 18201972; http://dx.doi.org/10.1074/jbc.M710396200
   PubMed Web of Science ®Google Scholar
• Götschel F, Kern C, Lang S, Sparna T, Markmann C, Schwager J, et al. Inhibition of GSK3 differentially modulates NFκB, CREB, AP-1 and β-catenin signaling in hepatocytes, but fails to promote TNFα-induced apoptosis. Exp Cell Res 2008; 314:1351 - 1366; PMID: 18261723; http://dx.doi.org/10.1016/j.yexcr.2007.12.015
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Brenner DA. Role of glycogen synthase kinase-3 in TNFα-induced NFκB activation and apoptosis in hepatocytes. Am J Physiol Gastrointest Liver Physiol 2002; 283:204 - 211; PMID: 12065308
   PubMed Web of Science ®Google Scholar
• Steinbrecher KA, Wilson W 3rd, Cogswell PC, Baldwin AS. Glycogen synthase kinase 3β functions to specify gene-specific, NFκB-dependent transcription. Mol Cell Biol 2005; 25:8444 - 8455; PMID: 16166627; http://dx.doi.org/10.1128/MCB.25.19.844455.2005
   PubMed Web of Science ®Google Scholar
• Bournat JC, Brown AM, Soler AP. Wnt-1 dependent activation of the survival factor NFκB in PC12 cells. J Neurosci Res 2000; 61:21 - 32; PMID: 10861796; http://dx.doi.org/10.1002/1097-4547(20000701)61:1<21::AIDJNR3>3.0.CO;2-7
   PubMed Web of Science ®Google Scholar
• Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB. Glycogen synthase kinase 3β-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor κB signaling. Mol Cell Biol 2003; 23:4649 - 4662; PMID: 12808104; http://dx.doi.org/10.1128/MCB.23.13.4649-62.2003
   PubMed Web of Science ®Google Scholar
• Bachelder RE, Yoon SO, Franci C, de Herreros AG, Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005; 168:29 - 33; PMID: 15631989; http://dx.doi.org/10.1083/jcb.200409067
   PubMed Web of Science ®Google Scholar
• Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991; 1072:129 - 157; PMID: 1751545
   PubMed Web of Science ®Google Scholar
• Tullai JW, Tacheva S, Owens LJ, Graham JR, Cooper GM. AP-1 Is a component of the transcriptional network regulated by GSK-3 in quiescent cells. PLoS ONE 2011; 6:20150; PMID: 21647439; http://dx.doi.org/10.1371/journal.pone.0020150
   PubMed Web of Science ®Google Scholar
• Cohen DR, Curran T. fra-1: a serum-inducible, cellular immediate early gene that encodes a fosrelated antigen. Mol Cell Biol 1988; 8:2063 - 2069; PMID: 3133553
   PubMed Web of Science ®Google Scholar
• Kovary K, Bravo R. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol Cell Biol 1991; 11:2451 - 2459; PMID: 1901942
   PubMed Web of Science ®Google Scholar
• Müller R, Bravo R, Burckhardt J, Curran T. Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature 1984; 312:716 - 720; PMID: 6334806; http://dx.doi.org/10.1038/312716a0
   PubMed Web of Science ®Google Scholar
• Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 1990; 87:3619 - 3623; PMID: 2110368; http://dx.doi.org/10.1073/pnas.87.9.3619
   PubMed Web of Science ®Google Scholar
• Morton S, Davis RJ, McLaren A, Cohen P. A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun. EMBO J 2003; 22:3876 - 3886; PMID: 12881422; http://dx.doi.org/10.1093/emboj/cdg388
   PubMed Web of Science ®Google Scholar
• Boyle WJ, Smeal T, Defize LH, Angel P, Woodgett JR, Karin M, et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 1991; 64:573 - 584; PMID: 1846781; http://dx.doi.org/10.1016/0092-8674(91)90241-P
   PubMed Web of Science ®Google Scholar
• Wei W, Jin J, Schlisio S, Harper JW, Kaelin WG Jr. The v-Jun point mutation allows c-Jun to escape GSK3-dependent recognition and destruction by the Fbw7 ubiquitin ligase. Cancer Cell 2005; 8:25 - 33; PMID: 16023596; http://dx.doi.org/10.1016/j.ccr.2005.06.005
   PubMed Web of Science ®Google Scholar
• Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001; 20:2438 - 2452; PMID: 11402339; http://dx.doi.org/10.1038/sj.onc.1204385
   PubMed Web of Science ®Google Scholar
• Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3:859 - 868; PMID: 14668816; http://dx.doi.org/10.1038/nrc1209
   PubMed Web of Science ®Google Scholar
• Ghosh S, Karin M. Missing pieces in the NFκB puzzle. Cell 2002; 109:81 - 96; PMID: 11983155; http://dx.doi.org/10.1016/S0092-8674(02)00703-1
   PubMed Web of Science ®Google Scholar
• Carlezon WA Jr, Duman RS, Nestler EJ. The many faces of CREB. Trends Neurosci 2005; 28:436 - 445; PMID: 15982754; http://dx.doi.org/10.1016/j.tins.2005.06.005
   PubMed Web of Science ®Google Scholar
• Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2001; 2:599 - 609; PMID: 11483993; http://dx.doi.org/10.1038/35085068
   PubMed Web of Science ®Google Scholar
• Nikolakaki E, Coffer PJ, Hemelsoet R, Woodgett JR, Defize LH. Glycogen synthase kinase-3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. Oncogene 1993; 8:833 - 840; PMID: 8384354
   PubMed Web of Science ®Google Scholar